Morfología-es: diferència entre les revisions
Cap resum de modificació |
Cap resum de modificació |
||
Línia 3: | Línia 3: | ||
La ICD-O-3.2 (en inglés: ''International Classification of Diseases for Oncology, 3rd edtion, 2nd revision)'' <ref>International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/ index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577</ref> también describe la morfología del tumor. Los códigos morfológicos son de cinco dígitos numéricos, identificando los cuatro primeros la histología y el quinto el comportamiento. Los valores de la histología van de M-8000 a M-9993 en la ICD-O-3.2 y los del comportamiento son 0: benigno; 1: incierto si es benigno o maligno; 2: in situ; 3: maligno, localización primaria; 6: maligno, localización metastásica; 9: maligno, incierto si es primario o metastásico.<ref>World Health Organization. ''International Classification of Diseases for Oncology. Third Edition. First Revision''. (Fritz A, Percy C, Jack A, et al., ed.).; 2013. https://apps.who.int/iris/handle/10665/42344</ref> El ''software'' ASEDAT propone una morfología para cada tumor, la cual se puede modificar manualmente. | La ICD-O-3.2 (en inglés: ''International Classification of Diseases for Oncology, 3rd edtion, 2nd revision)'' <ref>International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/ index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577</ref> también describe la morfología del tumor. Los códigos morfológicos son de cinco dígitos numéricos, identificando los cuatro primeros la histología y el quinto el comportamiento. Los valores de la histología van de M-8000 a M-9993 en la ICD-O-3.2 y los del comportamiento son 0: benigno; 1: incierto si es benigno o maligno; 2: in situ; 3: maligno, localización primaria; 6: maligno, localización metastásica; 9: maligno, incierto si es primario o metastásico.<ref>World Health Organization. ''International Classification of Diseases for Oncology. Third Edition. First Revision''. (Fritz A, Percy C, Jack A, et al., ed.).; 2013. https://apps.who.int/iris/handle/10665/42344</ref> El ''software'' ASEDAT propone una morfología para cada tumor, la cual se puede modificar manualmente. | ||
En Cataluña, los laboratorios de patología codifican los tumores con la terminología SNOMED CT (en inglés: ''Systematized Nomenclature of Medicine -Clinical Terms'')<ref>SNOMED International. SNOMED CT Release File Specifications. Published 2018. Accessed June 4, 2018. https:// confluence.ihtsdotools.org/display/DOCRELFMT/SNOMED+CT+Release+File+Specifications</ref> y con las codificaciones propuestas por la serie ''WHO Blue Books (en anglés: World Health Organization's International Histological of Tumors Series).''<ref>International Agency for Research on Cancer, World Health Organization. WHO Classification of Tumours. IARC, Lyon. Published 2018. Accessed June 6, 2018. https://whobluebooks.iarc.fr/</ref><ref>Fletcher CD., Bridge JA, Hogendoorn PC., Mertens F, ed. ''WHO Classification of Tumours of Soft Tissue and Bone''. 4th ed. International Agency for Research on Cancer; 2013. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours</ref><ref>Kurman RJ, Carcangiu ML, Herrington CS, Young RH, ed. ''WHO Classification of Tumours of Female Reproductive Organs''. 4th ed. International Agency for Research on Cancer; 2014. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours</ref><ref>Bosman FT, Carneiro F, Hruban RH, Theise ND, ed. ''WHO Classification of Tumours of the Digestive System''. 4th ed. International Agency for Research on Cancer; 2010. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref><ref>Lloyd R V., Osamura RY, Klöppel G, Rosai J, ed. ''WHO Classification of Tumours of Endocrine Organs''. 4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref><ref>El-Naggar AK, Chan JK., Grandis JR, Takata T, Slootweg PJ, ed. ''WHO Classification of Head and Neck Tumours''. 4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref><ref>LeBoit PE, Burg G, Weedon D, Sarasin A, ed. ''WHO Classification of Tumours. Pathology and Genetics of Skin Tumours''. IARC press; 2006. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/</ref><ref>Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, ed. ''WHO Classification of Tumours of the Central Nervous System''. Revised4th ed. International Agency for Research on Cancer; 2016. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours/</ref><ref>DeLellis ronald A, Lloyd R V, Heitz PU, Eng C, ed. ''WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs''. IARC Press; 2004. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of- Tumours/</ref><ref>Swerdlow SH, Campo E, Harris NL, et al., ed. ''WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues''. 4th ed. International Agency for Research on Cancer; 2008. https://publications.iarc.fr/Book-And-Report-Series/ Who-Classification-Of-Tumours/</ref><ref>Swerdlow SH, Campo E, Harris NL, et al., ed. ''WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues''. Revised4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours/</ref><ref>Moch H, Humphrey PA, Ulbright TM, Reuter VE, ed. ''WHO Classification of Tumours of the Urinary System and Male Genital Organs''. 4th ed. International Agency for Research on Cancer; 2016. https://publications.iarc.fr/Book-And- Report-Series/Who-Classification-Of-Tumours/</ref><ref>Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, ed. ''WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart''. 4th ed. International Agency for Research on Cancer; 2015. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours/</ref><ref>Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, ed. ''WHO Classification of Tumours of the Breast''. 4th ed. International Agency for Research on Cancer; 2012. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref> Estos códigos están disponibles en los laboratorios de Anatomía patológica mediante la extensión catalana de SNOMED CT.<ref>Sanz X, Pareja L, Rius A, et al. Definition of a SNOMED CT pathology subset and microglossary, based on 1.17 million biological samples from the Catalan Pathology Registry. ''J Biomed Inform''. 2018;78:167-176. https://doi. org/10.1016/j.jbi.2017.11.010</ref><ref>Sanz, X., Pareja, L., Rius, A., Gálvez, J., Escribà, J. M., Esteban, L., Borràs, J. M., & Ribes, J. How cancer registries can detect neoplasms in pathology laboratories that code with SNOMED CT terminology? An actual, simple and flexible solution. ''International Journal of Medical Informatics'',2020. ''141'', 104167. https://doi.org/10.1016/j.ijmedinf.2020.104167</ref><ref>Oficina d’Estàndards i Interoperabilitat de la Fundació TIC Salut Social. Departament de Salut. Generalitat de Catalunya. 8a. versió de l’extensió catalana de SNOMED CT. Published online 2018. https://ticsalutsocial.cat/ formulari-dobtencio-de-snomed-ct/</ref> Los códigos de la extensión catalana se muestran en el [ | En Cataluña, los laboratorios de patología codifican los tumores con la terminología SNOMED CT (en inglés: ''Systematized Nomenclature of Medicine -Clinical Terms'')<ref>SNOMED International. SNOMED CT Release File Specifications. Published 2018. Accessed June 4, 2018. https:// confluence.ihtsdotools.org/display/DOCRELFMT/SNOMED+CT+Release+File+Specifications</ref> y con las codificaciones propuestas por la serie ''WHO Blue Books (en anglés: World Health Organization's International Histological of Tumors Series).''<ref>International Agency for Research on Cancer, World Health Organization. WHO Classification of Tumours. IARC, Lyon. Published 2018. Accessed June 6, 2018. https://whobluebooks.iarc.fr/</ref><ref>Fletcher CD., Bridge JA, Hogendoorn PC., Mertens F, ed. ''WHO Classification of Tumours of Soft Tissue and Bone''. 4th ed. International Agency for Research on Cancer; 2013. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours</ref><ref>Kurman RJ, Carcangiu ML, Herrington CS, Young RH, ed. ''WHO Classification of Tumours of Female Reproductive Organs''. 4th ed. International Agency for Research on Cancer; 2014. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours</ref><ref>Bosman FT, Carneiro F, Hruban RH, Theise ND, ed. ''WHO Classification of Tumours of the Digestive System''. 4th ed. International Agency for Research on Cancer; 2010. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref><ref>Lloyd R V., Osamura RY, Klöppel G, Rosai J, ed. ''WHO Classification of Tumours of Endocrine Organs''. 4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref><ref>El-Naggar AK, Chan JK., Grandis JR, Takata T, Slootweg PJ, ed. ''WHO Classification of Head and Neck Tumours''. 4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref><ref>LeBoit PE, Burg G, Weedon D, Sarasin A, ed. ''WHO Classification of Tumours. Pathology and Genetics of Skin Tumours''. IARC press; 2006. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/</ref><ref>Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, ed. ''WHO Classification of Tumours of the Central Nervous System''. Revised4th ed. International Agency for Research on Cancer; 2016. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours/</ref><ref>DeLellis ronald A, Lloyd R V, Heitz PU, Eng C, ed. ''WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs''. IARC Press; 2004. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of- Tumours/</ref><ref>Swerdlow SH, Campo E, Harris NL, et al., ed. ''WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues''. 4th ed. International Agency for Research on Cancer; 2008. https://publications.iarc.fr/Book-And-Report-Series/ Who-Classification-Of-Tumours/</ref><ref>Swerdlow SH, Campo E, Harris NL, et al., ed. ''WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues''. Revised4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours/</ref><ref>Moch H, Humphrey PA, Ulbright TM, Reuter VE, ed. ''WHO Classification of Tumours of the Urinary System and Male Genital Organs''. 4th ed. International Agency for Research on Cancer; 2016. https://publications.iarc.fr/Book-And- Report-Series/Who-Classification-Of-Tumours/</ref><ref>Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, ed. ''WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart''. 4th ed. International Agency for Research on Cancer; 2015. https://publications.iarc.fr/Book-And-Report- Series/Who-Classification-Of-Tumours/</ref><ref>Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, ed. ''WHO Classification of Tumours of the Breast''. 4th ed. International Agency for Research on Cancer; 2012. https://publications.iarc.fr/Book-And-Report-Series/Who- Classification-Of-Tumours/</ref> Estos códigos están disponibles en los laboratorios de Anatomía patológica mediante la extensión catalana de SNOMED CT.<ref>Sanz X, Pareja L, Rius A, et al. Definition of a SNOMED CT pathology subset and microglossary, based on 1.17 million biological samples from the Catalan Pathology Registry. ''J Biomed Inform''. 2018;78:167-176. https://doi. org/10.1016/j.jbi.2017.11.010</ref><ref>Sanz, X., Pareja, L., Rius, A., Gálvez, J., Escribà, J. M., Esteban, L., Borràs, J. M., & Ribes, J. How cancer registries can detect neoplasms in pathology laboratories that code with SNOMED CT terminology? An actual, simple and flexible solution. ''International Journal of Medical Informatics'',2020. ''141'', 104167. https://doi.org/10.1016/j.ijmedinf.2020.104167</ref><ref>Oficina d’Estàndards i Interoperabilitat de la Fundació TIC Salut Social. Departament de Salut. Generalitat de Catalunya. 8a. versió de l’extensió catalana de SNOMED CT. Published online 2018. https://ticsalutsocial.cat/ formulari-dobtencio-de-snomed-ct/</ref> Los códigos de la extensión catalana se muestran en el [[Extensión catalana: conceptos de la serie WHO Blue Series-es|anexo 1]]. | ||
Revisió de 09:46, 29 juny 2022
La ICD-O-3.2 (en inglés: International Classification of Diseases for Oncology, 3rd edtion, 2nd revision) [1] también describe la morfología del tumor. Los códigos morfológicos son de cinco dígitos numéricos, identificando los cuatro primeros la histología y el quinto el comportamiento. Los valores de la histología van de M-8000 a M-9993 en la ICD-O-3.2 y los del comportamiento son 0: benigno; 1: incierto si es benigno o maligno; 2: in situ; 3: maligno, localización primaria; 6: maligno, localización metastásica; 9: maligno, incierto si es primario o metastásico.[2] El software ASEDAT propone una morfología para cada tumor, la cual se puede modificar manualmente.
En Cataluña, los laboratorios de patología codifican los tumores con la terminología SNOMED CT (en inglés: Systematized Nomenclature of Medicine -Clinical Terms)[3] y con las codificaciones propuestas por la serie WHO Blue Books (en anglés: World Health Organization's International Histological of Tumors Series).[4][5][6][7][8][9][10][11][12][13][14][15][16][17] Estos códigos están disponibles en los laboratorios de Anatomía patológica mediante la extensión catalana de SNOMED CT.[18][19][20] Los códigos de la extensión catalana se muestran en el anexo 1.
Referencias bibliográficas
- ↑ International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
- ↑ World Health Organization. International Classification of Diseases for Oncology. Third Edition. First Revision. (Fritz A, Percy C, Jack A, et al., ed.).; 2013. https://apps.who.int/iris/handle/10665/42344
- ↑ SNOMED International. SNOMED CT Release File Specifications. Published 2018. Accessed June 4, 2018. https://+confluence.ihtsdotools.org/display/DOCRELFMT/SNOMED+CT+Release+File+Specifications
- ↑ International Agency for Research on Cancer, World Health Organization. WHO Classification of Tumours. IARC, Lyon. Published 2018. Accessed June 6, 2018. https://whobluebooks.iarc.fr/
- ↑ Fletcher CD., Bridge JA, Hogendoorn PC., Mertens F, ed. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. International Agency for Research on Cancer; 2013. https://publications.iarc.fr/Book-And-Report-Series/Who-+Classification-Of-Tumours
- ↑ Kurman RJ, Carcangiu ML, Herrington CS, Young RH, ed. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. International Agency for Research on Cancer; 2014. https://publications.iarc.fr/Book-And-Report-+Series/Who-Classification-Of-Tumours
- ↑ Bosman FT, Carneiro F, Hruban RH, Theise ND, ed. WHO Classification of Tumours of the Digestive System. 4th ed. International Agency for Research on Cancer; 2010. https://publications.iarc.fr/Book-And-Report-Series/Who-+Classification-Of-Tumours/
- ↑ Lloyd R V., Osamura RY, Klöppel G, Rosai J, ed. WHO Classification of Tumours of Endocrine Organs. 4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report-Series/Who-+Classification-Of-Tumours/
- ↑ El-Naggar AK, Chan JK., Grandis JR, Takata T, Slootweg PJ, ed. WHO Classification of Head and Neck Tumours. 4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report-Series/Who-+Classification-Of-Tumours/
- ↑ LeBoit PE, Burg G, Weedon D, Sarasin A, ed. WHO Classification of Tumours. Pathology and Genetics of Skin Tumours. IARC press; 2006. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/
- ↑ Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, ed. WHO Classification of Tumours of the Central Nervous System. Revised4th ed. International Agency for Research on Cancer; 2016. https://publications.iarc.fr/Book-And-Report-+Series/Who-Classification-Of-Tumours/
- ↑ DeLellis ronald A, Lloyd R V, Heitz PU, Eng C, ed. WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. IARC Press; 2004. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-+Tumours/
- ↑ Swerdlow SH, Campo E, Harris NL, et al., ed. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer; 2008. https://publications.iarc.fr/Book-And-Report-Series/+Who-Classification-Of-Tumours/
- ↑ Swerdlow SH, Campo E, Harris NL, et al., ed. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised4th ed. International Agency for Research on Cancer; 2017. https://publications.iarc.fr/Book-And-Report-+Series/Who-Classification-Of-Tumours/
- ↑ Moch H, Humphrey PA, Ulbright TM, Reuter VE, ed. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. International Agency for Research on Cancer; 2016. https://publications.iarc.fr/Book-And-+Report-Series/Who-Classification-Of-Tumours/
- ↑ Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, ed. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. International Agency for Research on Cancer; 2015. https://publications.iarc.fr/Book-And-Report-+Series/Who-Classification-Of-Tumours/
- ↑ Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, ed. WHO Classification of Tumours of the Breast. 4th ed. International Agency for Research on Cancer; 2012. https://publications.iarc.fr/Book-And-Report-Series/Who-+Classification-Of-Tumours/
- ↑ Sanz X, Pareja L, Rius A, et al. Definition of a SNOMED CT pathology subset and microglossary, based on 1.17 million biological samples from the Catalan Pathology Registry. J Biomed Inform. 2018;78:167-176. https://doi.+org/10.1016/j.jbi.2017.11.010
- ↑ Sanz, X., Pareja, L., Rius, A., Gálvez, J., Escribà, J. M., Esteban, L., Borràs, J. M., & Ribes, J. How cancer registries can detect neoplasms in pathology laboratories that code with SNOMED CT terminology? An actual, simple and flexible solution. International Journal of Medical Informatics,2020. 141, 104167. https://doi.org/10.1016/j.ijmedinf.2020.104167
- ↑ Oficina d’Estàndards i Interoperabilitat de la Fundació TIC Salut Social. Departament de Salut. Generalitat de Catalunya. 8a. versió de l’extensió catalana de SNOMED CT. Published online 2018. https://ticsalutsocial.cat/+formulari-dobtencio-de-snomed-ct/